Michihiro Satoh(a), Akihiro Matsumoto(b), Azusa Hara(c), Saki Iwamori(b), Taku Obara(a),(d), Masahiro Kikuya(d), Hirohito Metoki(e), Miki Hosaka(f), Kei Asayama(f),(g), Nobuyuki Takahashi(b), Hiroshi Sato(b), Nariyasu Mano(a), Yutaka Imai(f), Takayoshi Ohkubo(g)
(a)Department of Pharmacy, Tohoku University Hospital, (b)Department of Clinical Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Tohoku University, (c)Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, (d)Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, (e)Department of Community Medical Supports, Tohoku Medical Megabank Organization, Tohoku University, (f)Department of Planning for Drug Development and Clinical Evaluation, Graduate School of Pharmaceutical Sciences, Tohoku University, (g)Department of Hygiene and Public Health, Teikyo University School of Medicine
YAKUGAKU ZASSHI (Journal of the Pharmaceutical Society of Japan) 134(12): 1347-1355, 2014.